A new Phase 2 clinical trial at the Angeles Clinic will study tremelimumab as an immunotherapy treatment for pleural and peritoneal mesothelioma.
A new Phase 2 clinical trial at the Angeles Clinic will study tremelimumab as an immunotherapy treatment for pleural and peritoneal mesothelioma.